FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
Center | Date | Time | Location |
---|---|---|---|
NCTR | January 21, 2004 | 8 a.m. - 3:30 p.m. | Food & Drug
Administration |
Agenda:
The U.S. Air Force will provide a program management update and present information
on the following topics: Syndrome X; cancer and hepatitis in the comparison
group vs. years in Southeast Asia; prostate cancer; adipose tissue study results;
and memory loss and end of study transition.
Procedure:
Interested persons may present data, information, or views, orally or in writing,
on issues pending before the committee. Written submissions may be made to the
contact person by January 9, 2004. Oral presentations from the public will be
scheduled between approximately 1:30 p.m. to 2:30 p.m.. Time allotted for each
presentation may be limited. Those desiring to make formal oral presentations
should notify the contact person before January 6, 2004, and submit a brief
statement of the general nature of the evidence or arguments they wish to present,
the names and addresses of proposed participants, and an indication of the approximate
time requested to make their presentation. Persons attending FDA's advisory
committee meetings are advised that the agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the public at its advisory committee meetings
and will make every effort to accommodate persons with physical disabilities
or special needs. If you require special accommodations due to a disability,
please contact Leonard Schechtman at least 7 days in advance of the meeting.
Contact Person:
Leonard Schechtman, National Center for Toxicological Research
(HFT–10), Food and Drug Administration, 5600 Fishers Lane, Rockville,
MD 20857, 301–827–6696,, or FDA Advisory Committee Information Line,
1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512560. Please
call the Information Line for up-to-date information on this meeting.